133 related articles for article (PubMed ID: 36398488)
1. A self-delivery photodynamic sensitizer for enhanced DNA damage by PARP inhibition.
Kong RJ; Li XY; Huang JQ; Zhou X; Deng FA; Li YM; Liu LS; Li SY; Cheng H
Biomater Sci; 2022 Dec; 11(1):162-169. PubMed ID: 36398488
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
3. PARP inhibitors diminish DNA damage repair for the enhancement of tumor photodynamic therapy.
Lei S; Ge F; Lin M; Wang X; Shen J; Yang Y; Deng J; Wang Z; Wang J; Li K
Photodiagnosis Photodyn Ther; 2022 Dec; 40():103058. PubMed ID: 35944846
[TBL] [Abstract][Full Text] [Related]
4. Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer.
Tanaka M; Sasaki M; Suzuki T; Nishie H; Kataoka H
Biochem Biophys Res Commun; 2021 Feb; 539():1-7. PubMed ID: 33388624
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional biomimetic nanoplatform based on photodynamic therapy and DNA repair intervention for the synergistic treatment of breast cancer.
Wu H; Du X; Xu J; Kong X; Li Y; Liu D; Yang X; Ye L; Ji J; Xi Y; Zhai G
Acta Biomater; 2023 Feb; 157():551-565. PubMed ID: 36513248
[TBL] [Abstract][Full Text] [Related]
6. Carrier-Free Nano-PROTACs to Amplify Photodynamic Therapy Induced DNA Damage through BRD4 Degradation.
Zhao LP; Rao XN; Zheng RR; Huang CY; Kong RJ; Cheng H; Li B; Li SY
Nano Lett; 2023 Jul; 23(13):6193-6201. PubMed ID: 37387510
[TBL] [Abstract][Full Text] [Related]
7. Self-delivery biomedicine for enhanced photodynamic therapy by feedback promotion of tumor autophagy.
Chen SY; Zhao LP; Chen ZX; Huang CY; Kong RJ; Wang YQ; Zhang DW; Li SY; Ti HH; Cheng H
Acta Biomater; 2023 Mar; 158():599-610. PubMed ID: 36603734
[TBL] [Abstract][Full Text] [Related]
8. Carrier free nanomedicine to reverse anti-apoptosis and elevate endoplasmic reticulum stress for enhanced photodynamic therapy.
Zhou X; Li Y; Li X; Huang J; Kong R; Liu L; Cheng H
Acta Biomater; 2022 Oct; 152():507-518. PubMed ID: 36030050
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy (PDT) resistance by PARP1 regulation on PDT-induced apoptosis with autophagy in head and neck cancer cells.
Kim J; Lim W; Kim S; Jeon S; Hui Z; Ni K; Kim C; Im Y; Choi H; Kim O
J Oral Pathol Med; 2014 Oct; 43(9):675-84. PubMed ID: 24931630
[TBL] [Abstract][Full Text] [Related]
10. Nuclear PARP1-Targeted Photosensitizer as a Dual-Mode DNA-Damaging Agent and Immune Activator for Tumor Ablation.
Li P; Du Y; Qiu J; Li D; Li G; Shan G
Adv Healthc Mater; 2023 Dec; 12(31):e2301517. PubMed ID: 37689990
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
12. Self-Delivery Nanomedicine for Glutamine-Starvation Enhanced Photodynamic Tumor Therapy.
Zhao LP; Chen SY; Zheng RR; Kong RJ; Rao XN; Chen AL; Cheng H; Zhang DW; Li SY; Yu XY
Adv Healthc Mater; 2022 Feb; 11(3):e2102038. PubMed ID: 34729950
[TBL] [Abstract][Full Text] [Related]
13. MOF@COF Nanocapsules Enhance Soft Tissue Sarcoma Treatment: Synergistic Effects of Photodynamic Therapy and PARP Inhibition on Tumor Growth Suppression and Immune Response Activation.
Tai Y; Chen Z; Luo T; Luo B; Deng C; Lu Z; Wen S; Wang J
Adv Healthc Mater; 2024 Apr; 13(11):e2303911. PubMed ID: 38215731
[TBL] [Abstract][Full Text] [Related]
14. Chlorin e6 mediated photodynamic therapy triggers resistance through ATM-related DNA damage response in lung cancer cells.
Ma QL; Shen MO; Han N; Xu HZ; Peng XC; Li QR; Yu TT; Li LG; Xu X; Liu B; Chen X; Wang MF; Li TF
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102645. PubMed ID: 34823034
[TBL] [Abstract][Full Text] [Related]
15. Carrier Free Photodynamic Synergists for Oxidative Damage Amplified Tumor Therapy.
Li XY; Deng FA; Zheng RR; Liu LS; Liu YB; Kong RJ; Chen AL; Yu XY; Li SY; Cheng H
Small; 2021 Oct; 17(40):e2102470. PubMed ID: 34480417
[TBL] [Abstract][Full Text] [Related]
16. Self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy.
Liu Y; Deng F; Zheng R; Chen X; Zhao L; Yu B; Chen A; Jiang X; Cheng H; Li S
J Colloid Interface Sci; 2022 Apr; 612():562-571. PubMed ID: 35026565
[TBL] [Abstract][Full Text] [Related]
17. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells.
Marijon H; Lee DH; Ding L; Sun H; Gery S; de Gramont A; Koeffler HP
Biomed Pharmacother; 2018 Mar; 99():543-551. PubMed ID: 29902865
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment.
Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X
Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955
[TBL] [Abstract][Full Text] [Related]
19. The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review.
Lau CH; Seow KM; Chen KH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897700
[TBL] [Abstract][Full Text] [Related]
20. Feedback-Elevated Antitumor Amplifier of Self-Delivery Nanomedicine by Suppressing Photodynamic Therapy-Caused Inflammation.
Li XY; Li YM; Kong RJ; Yan N; Zhou X; Huang JQ; Wang T; Li SY; Cheng H
ACS Appl Bio Mater; 2023 Jul; 6(7):2816-2825. PubMed ID: 37326439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
